-
Popular weight loss and diabetes drugs linked to increased risk of rare form of blindness. Study authors state that causality is not established. The health benefits of controlling diabetes, reduced heart, liver, kidney, and brain disease need to be considered with its use.
Medical Mythbusting Commentary for July 4, 2024 Source:Popular weight loss and diabetes drugs linked to increased risk of rare form of blindness
-
Sunday House Call, #909, January 14, 2024: How health insurance company wanna-be-doctor bean counter’s medication-coverage decisions interfere with therapeutic management and has had a deleterious effect on (my) patients’ health outcomes.
I talked about this before yet this continues to be a major issue in that evidence-based medicine is being thwarted by insurance companies’ decision to not provide Semaglutide (Ozempic) for the treatment and management of obesity. It is having a deleterious effect both from a mental and physical health perspective on my patients. Wasn’t the…
-
U.S. pharmacies that are compounding unregulated vials of semaglutide for sale during the Ozempic shortage has led to Poison centers reporting a 1,500% increase in calls related to accidental overdose.
Medical Mythbusting Commentary for December 15, 2023 Source:Poison centers see nearly 1,500% increase in calls related to injected weight-loss drugs as people accidentally overdose